CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Post by Growth100Percnton Mar 24, 2019 6:00pm

76 Views

Post# 29529206

March 20th/2018 Interview with Tony Robbins

https://www.kereport.com/2018/03/20/cvr-medical-timelines-additional-trials-fda-clearance/

He points out the approval process to be 90-120 days.
I thought that was interesting.
131 days is the average.
So it could possibly be given before that.

Bullboard Posts

Eminent acquires promising Nevada gold project